Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Target-Date · MFS

MFS Lifetime 2070 Fund A (LFTQX)

Ticker LFTQX · · Holdings as of Jul 31, 2026

Expense ratio
0.8%$80/yr per $10k
Net assets
$1.2Mall share classes
Holdings
24

Bottom line

Is LFTQX a good fund? The bottom line

LFTQX is the A share class of MFS Lifetime 2070 Fund, a managed target-date mutual fund from MFS.

Its expense ratio is 0.8% — about $80 a year on every $10,000 invested, more expensive than 72% of target-date funds we track.

With $1.2 million in net assets and 24 holdings, its largest position is MFS Blended Research International Equity Fund (11.2%) and the top 10 make up 62.9% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Expensive for its category (0.8%)
  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($1.2 million) — small funds are likelier to close

Updated Nov 19, 2026

What LFTQX invests in

The funds investment objective is to seek a high level of total return consistent with its asset allocation until the approximate retirement year in the fund's name; thereafter, the fund will seek total return through a combination of current income and capital appreciation. The asset allocation of the fund will change over time.

The fund is designed to provide diversification among different asset classes for investors with the approximate retirement year in the fund's name. MFS (Massachusetts Financial Services Company, the fund's investment adviser) invests substantially all of the fund's assets in other MFS mutual funds, referred to as underlying funds. MFS selects the asset class allocations based on a strategic asset allocation process that takes into account a variety of factors, including historical risk and performance, projected performance, and other factors. MFS analyses of projected performance are primarily based on quantitative models using various inputs such as valuation metrics, growth rates, profitability, yields, and inflation. MFS may also consider current market conditions, its qualitative assessment of the risk/return characteristics of asset classes, and other factors in determining…

From the fund's prospectus (filed Jun 1, 2026).

What LFTQX costs

On a $10,000 investment, LFTQX's 0.8% expense ratio costs about $80 a year. The median target-date fund charges 0.59%.

See the full LFTQX fee table →

LFTQX top 10 holdings

#Holding% of fund
1MFS Blended Research International Equity Fund11.25%
2MFS Blended Research Mid Cap Equity Fund10.19%
3MFS Blended Research Value Equity Fund5.67%
4MFS Value Fund5.63%
5MFS Global Real Estate Fund5.27%
6MFS Mid Cap Value Fund5.10%
7MFS Commodity Strategy Fund5.00%
8MFS Blended Research Growth Equity Fund4.97%
9MFS Growth Fund4.95%
10MFS Mid Cap Growth Fund4.89%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 62.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to LFTQX

More funds like LFTQX →

LFTQX FAQ

What is the expense ratio of LFTQX?
LFTQX's expense ratio is 0.8%, which works out to about $80 a year for every $10,000 invested.
Is LFTQX a good investment?
It depends on your goals, but the data points to: expensive for its category (0.8%); front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year; small fund ($1.2 million) — small funds are likelier to close. This is general information, not personalized advice.
What does LFTQX hold?
LFTQX's largest holdings are MFS Blended Research International Equity Fund (11.2%), MFS Blended Research Mid Cap Equity Fund (10.2%), MFS Blended Research Value Equity Fund (5.7%), MFS Value Fund (5.6%), MFS Global Real Estate Fund (5.3%). It holds 24 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Does LFTQX have a sales load?
Yes. LFTQX has a maximum front-end sales charge of 5.75%. It may charge a deferred sales charge of up to 1% if sold early.
Who manages LFTQX?
LFTQX is offered by MFS through Mfs Series Trust Xii.